SS Innovations International, Inc.

SSII Healthcare Medical Devices

SS Innovations International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $42.5 million, up 105.7% from fiscal 2024. In the quarter to June 2026, revenue grew 39.4%, EPS fell 669.2%, free cash flow fell 16.6% and total debt rose 109.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

2.55 0.03 −1.16%
Market cap
$517.2M
P/E
0.0×
Fwd P/E
−63.0×
Dividend yield
—
F-score
5/9
Altman Z
17.50
Beneish M
−0.72
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
3 4 5 —

+8 more TTM periods

ROE
(26.06%) (21.10%) (46.94%) (43.25%)
ROA
(14.89%) (13.02%) (20.80%) (21.57%)
ROIC
(11.31%) (8.78%) (12.64%) (15.62%)
Return on Tangible Assets
(25.80%) (20.45%) (38.34%) (32.63%)
Average Days of Receivables
118.31 105.85 106.52 70.00
Free Cash Flow per Share
(0.09) (0.09) (0.12) (0.12)
Free Cash Flow
(18.22) (17.59) (22.20) (22.35)
Other line items

Show all line items

Columns are period end dates